Literature DB >> 14522302

Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit.

Gregor Wollensak1, Eberhard Spoerl, Michaela Wilsch, Theo Seiler.   

Abstract

PURPOSE: To evaluate the possible cytotoxic effect of combined riboflavin-ultraviolet-A (UVA) treatment on the corneal endothelium.
SETTING: Department of Ophthalmology, Technical University of Dresden, Dresden, Germany.
METHODS: The right eyes of 34 New Zealand White rabbits were treated with riboflavin and various endothelial UVA doses ranging from 0.16 to 0.9 J/cm2 (0.09 to 0.5 mW/cm2, 370 nm) and postoperative enucleation times of 4 hours and 24 hours. The endothelial cells were evaluated in histological sections. The terminal deoxynulceotidyl transferase deoxy-UTP-nick-end labeling (TUNEL) technique and transmission electron microscopy were used to detect apoptosis.
RESULTS: There was no endothelial damage in the 6 rabbit eyes enucleated at 4 hours. In those enucleated at 24 hours, there was significant necrosis and apoptosis of endothelial cells in the corneas treated with an endothelial dose of > or =0.65 J/cm2 (0.36 mW/cm2), which is about twice the endothelial UVA dose used in the treatment of keratoconus patients.
CONCLUSIONS: In rabbit corneas with a corneal thickness less than 400 microm, the endothelial UVA dose reached a cytotoxic level of > or =0.65 J/cm2 (0.36 mW/cm2) using the standard surface UVA dose of 5.4 J/cm2 (3 mW/cm2). Pachymetry should be routinely performed before riboflavin-UVA treatment; in thinner corneas, irradiation should not be done because of the cytotoxic risk to the endothelium.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14522302     DOI: 10.1016/s0886-3350(03)00343-2

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  68 in total

1.  [Corneal melting in both eyes after simultaneous corneal cross-linking in a patient with keratoconus and Down syndrome].

Authors:  C Faschinger; R Kleinert; A Wedrich
Journal:  Ophthalmologe       Date:  2010-10       Impact factor: 1.059

2.  [Enzymatic evidence of the depth dependence of stiffening on riboflavin/UVA treated corneas].

Authors:  T Schilde; M Kohlhaas; E Spoerl; L E Pillunat
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

Review 3.  Corneal collagen crosslinking in keratoconus and other eye disease.

Authors:  Adel Alhayek; Pei-Rong Lu
Journal:  Int J Ophthalmol       Date:  2015-04-18       Impact factor: 1.779

Review 4.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

5.  A short-term study of corneal collagen cross-linking with hypo-osmolar riboflavin solution in keratoconic corneas.

Authors:  Shao-Feng Gu; Zhao-Shan Fan; Li-Hua Wang; Xiang-Chen Tao; Yong Zhang; Chun-Qin Wang; Ya Wang; Guo-Ying Mu
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

6.  Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium.

Authors:  Yuntao Zhang; Pinakin Sukthankar; John M Tomich; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

Review 7.  Corneal collagen cross-linking: a review.

Authors:  David P S O'Brart
Journal:  J Optom       Date:  2014-03-20

8.  [Collagen crosslinking with riboflavin and UVA-light in keratoconus].

Authors:  M Kohlhaas
Journal:  Ophthalmologe       Date:  2008-08       Impact factor: 1.059

9.  Corneal collagen cross-linking.

Authors:  Mirko R Jankov Ii; Vesna Jovanovic; Ljubisa Nikolic; Jonathan C Lake; Georgos Kymionis; Efekan Coskunseven
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

10.  Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus.

Authors:  Tamer M El-Raggal
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.